Today's Analyst Stock Ratings | Upgrades, Downgrades

SPY778.78+0.03%QQQ749.91−0.18%BTC/USD82,736.40−1.13%DIA516.44+0.06%GLD381.68−0.75%TLT77.81−0.22%

							Get Alert
Oct 6, 2026	PGProcter & Gamble	$150.79	10.08%	Robert OttensteinEvercore ISI Group 53%	161 166	Previous In-Line Current Outperform	Get Alert
Oct 6, 2026	PGProcter & Gamble	$150.79	10.08%	Nik ModiRBC Capital 50%	166 167	Previous Outperform Current Outperform	Get Alert
Sep 30, 2026	PGProcter & Gamble	$150.79	-0.53%	Robert MoskowTD Cowen 65%	150 150	Previous Hold Current Hold	Get Alert
Aug 7, 2026	PGProcter & Gamble	$150.79	—	Taylor ConradArgus Research 48%	—	Previous Buy Current Hold	Get Alert
Jul 30, 2026	PGProcter & Gamble	$150.79	-1.19%	—	149 182	Previous Buy Current Hold	Get Alert
Jul 30, 2026	PGProcter & Gamble	$150.79	12.74%	Filippo FalorniCitigroup 57%	170 181	Previous Buy Current Buy	Get Alert
Jul 21, 2026	PGProcter & Gamble	$150.79	0.8%	Lauren LiebermanBarclays 64%	146 152	Previous Equal-Weight Current Equal-Weight	Get Alert
Jul 16, 2026	PGProcter & Gamble	$150.79	7.43%	Andrea TeixeiraJP Morgan 62%	162 164	Previous Overweight Current Overweight	Get Alert
Jul 10, 2026	PGProcter & Gamble	$150.79	10.08%	Peter GalboB of A Securities 58%	166 170	Previous Buy Current Buy	Get Alert
Jun 11, 2026	PGProcter & Gamble	$150.79	3.45%	Cristian RiosBernstein 46%	156	Previous Initiates Current Market Perform	Get Alert
Apr 27, 2026	PGProcter & Gamble	$150.79	14.06%	Peter GromUBS 62%	166 172	Previous Buy Current Buy	Get Alert
Apr 27, 2026	PGProcter & Gamble	$150.79	-0.53%	Robert MoskowTD Cowen 65%	142 150	Previous Hold Current Hold	Get Alert
Apr 27, 2026	PGProcter & Gamble	$150.79	8.76%	Chris CareyWells Fargo 62%	158 164	Previous Overweight Current Overweight	Get Alert
Apr 27, 2026	PGProcter & Gamble	$150.79	7.43%	Robert OttensteinEvercore ISI Group 53%	162 170	Previous In-Line Current In-Line	Get Alert
Apr 17, 2026	PGProcter & Gamble	$150.79	7.43%	Andrea TeixeiraJP Morgan 62%	162 165	Previous Overweight Current Overweight	Get Alert
Apr 14, 2026	PGProcter & Gamble	$150.79	-3.18%	Lauren LiebermanBarclays 64%	146 155	Previous Equal-Weight Current Equal-Weight	Get Alert
Apr 10, 2026	PGProcter & Gamble	$150.79	10.75%	Peter GalboB of A Securities 58%	167 171	Previous Buy Current Buy	Get Alert
Apr 8, 2026	PGProcter & Gamble	$150.79	4.78%	Chris CareyWells Fargo 62%	158 177	Previous Overweight Current Overweight	Get Alert
Apr 8, 2026	PGProcter & Gamble	$150.79	-5.83%	Michael LaveryPiper Sandler 61%	142 150	Previous Neutral Current Neutral	Get Alert
Apr 7, 2026	PGProcter & Gamble	$150.79	10.08%	Peter GromUBS 62%	166 170	Previous Buy Current Buy	Get Alert
Mar 30, 2026	PGProcter & Gamble	$150.79	7.43%	Steve PowersDeutsche Bank 66%	162 171	Previous Hold Current Hold	Get Alert
Jan 27, 2026	PGProcter & Gamble	$150.79	3.45%	Robert MoskowTD Cowen 65%	150 156	Previous Buy Current Hold	Get Alert
Jan 23, 2026	PGProcter & Gamble	$150.79	12.74%	Peter GromUBS 62%	161 170	Previous Buy Current Buy	Get Alert
Jan 23, 2026	PGProcter & Gamble	$150.79	9.42%	Chris CareyWells Fargo 62%	158 165	Previous Overweight Current Overweight	Get Alert
Jan 23, 2026	PGProcter & Gamble	$150.79	9.42%	Andrea TeixeiraJP Morgan 62%	157 165	Previous Neutral Current Overweight	Get Alert
Jan 14, 2026	PGProcter & Gamble	$150.79	6.77%	Peter GromUBS 62%	161 176	Previous Buy Current Buy	Get Alert
Jan 8, 2026	PGProcter & Gamble	$150.79	-0.53%	Robert MoskowTD Cowen 65%	150 168	Previous Buy Current Buy	Get Alert
Jan 5, 2026	PGProcter & Gamble	$150.79	4.78%	Chris CareyWells Fargo 62%	158 170	Previous Overweight Current Overweight	Get Alert
Dec 18, 2025	PGProcter & Gamble	$150.79	4.12%	Andrea TeixeiraJP Morgan 62%	157 165	Previous Neutral Current Neutral	Get Alert
Dec 17, 2025	PGProcter & Gamble	$150.79	18.71%	Kaumil GajrawalaJefferies 52%	156 179	Previous Hold Current Buy	Get Alert
Oct 29, 2025	PGProcter & Gamble	$150.79	12.07%	Georgy VashchenkoFreedom Broker 39%	164 169	Previous Hold Current Hold	Get Alert
Oct 27, 2025	PGProcter & Gamble	$150.79	9.42%	Andrea TeixeiraJP Morgan 62%	163 165	Previous Neutral Current Neutral	Get Alert
Oct 20, 2025	PGProcter & Gamble	$150.79	16.05%	Olivia TongRaymond James 67%	175 185	Previous Outperform Current Outperform	Get Alert
Oct 10, 2025	PGProcter & Gamble	$150.79	8.1%	Andrea TeixeiraJP Morgan 62%	163 170	Previous Neutral Current Neutral	Get Alert
Oct 8, 2025	PGProcter & Gamble	$150.79	15.39%	Olivia TongB of A Securities 67%	174 180	Previous Buy Current Buy	Get Alert
Oct 8, 2025	PGProcter & Gamble	$150.79	16.72%	Peter GromUBS 62%	176 180	Previous Buy Current Buy	Get Alert
Oct 1, 2025	PGProcter & Gamble	$150.79	1.46%	Lauren LiebermanBarclays 64%	153 164	Previous Equal-Weight Current Equal-Weight	Get Alert
Sep 25, 2025	PGProcter & Gamble	$150.79	12.74%	Chris CareyWells Fargo 62%	170 173	Previous Overweight Current Overweight	Get Alert
Aug 15, 2025	PGProcter & Gamble	$150.79	17.38%	Kevin GrundyBNP Paribas 53%	177 177	Previous Outperform Current Outperform	Get Alert
Jul 31, 2025	PGProcter & Gamble	$150.79	8.76%	Georgy VashchenkoFreedom Broker 39%	164 172	Previous Hold Current Hold	Get Alert
Jul 31, 2025	PGProcter & Gamble	$150.79	8.76%	Lauren LiebermanBarclays 64%	161 164	Previous Equal-Weight Current Equal-Weight	Get Alert
Jul 30, 2025	PGProcter & Gamble	$150.79	14.73%	Chris CareyWells Fargo 62%	173 175	Previous Overweight Current Overweight	Get Alert
Jul 25, 2025	PGProcter & Gamble	$150.79	12.74%	Andrea TeixeiraJP Morgan 62%	170 178	Previous Overweight Current Neutral	Get Alert
Jul 17, 2025	PGProcter & Gamble	$150.79	19.37%	Peter GromUBS 62%	180 186	Previous Buy Current Buy	Get Alert
Jul 15, 2025	PGProcter & Gamble	$150.79	6.77%	Lauren LiebermanBarclays 64%	160 161	Previous Equal-Weight Current Equal-Weight	Get Alert
Jul 14, 2025	PGProcter & Gamble	$150.79	12.74%	Robert OttensteinEvercore ISI Group 53%	170 190	Previous Outperform Current In-Line	Get Alert
Jun 3, 2025	PGProcter & Gamble	$150.79	26%	Robert OttensteinEvercore ISI Group 53%	170 190	Previous Outperform Current Outperform	Get Alert
May 5, 2025	PGProcter & Gamble	$150.79	8.76%	Korinne WolfmeyerPiper Sandler 49%	160 164	Previous Neutral Current Neutral	Get Alert
Apr 25, 2025	PGProcter & Gamble	$150.79	19.37%	Dara MohsenianMorgan Stanley 73%	180 191	Previous Overweight Current Overweight	Get Alert
Apr 25, 2025	PGProcter & Gamble	$150.79	17.38%	Nik ModiRBC Capital 50%	164 177	Previous Sector Perform Current Outperform	Get Alert
Apr 25, 2025	PGProcter & Gamble	$150.79	19.37%	Bill ChappellTruist Securities 41%	180 185	Previous Buy Current Buy	Get Alert
Apr 25, 2025	PGProcter & Gamble	$150.79	22.68%	Olivia TongRaymond James 67%	185 190	Previous Outperform Current Outperform	Get Alert
Apr 25, 2025	PGProcter & Gamble	$150.79	20.03%	Filippo FalorniCitigroup 57%	181 200	Previous Buy Current Buy	Get Alert
Apr 25, 2025	PGProcter & Gamble	$150.79	19.37%	Olivia TongB of A Securities 67%	180 190	Previous Buy Current Buy	Get Alert
Apr 22, 2025	PGProcter & Gamble	$150.79	8.76%	Nik ModiRBC Capital 50%	164 164	Previous Sector Perform Current Sector Perform	Get Alert
Apr 11, 2025	PGProcter & Gamble	$150.79	14.06%	Andrea TeixeiraJP Morgan 62%	172 181	Previous Overweight Current Overweight	Get Alert
Apr 3, 2025	PGProcter & Gamble	$150.79	22.68%	Bill ChappellTruist Securities 41%	180 185	Previous Buy Current Buy	Get Alert
Mar 27, 2025	PGProcter & Gamble	$150.79	9.42%	Lauren LiebermanBarclays 64%	159 165	Previous Equal-Weight Current Equal-Weight	Get Alert
Feb 24, 2025	PGProcter & Gamble	$150.79	14.06%	Korinne WolfmeyerPiper Sandler 49%	172 173	Previous Neutral Current Neutral	Get Alert
Jan 23, 2025	PGProcter & Gamble	$150.79	8.76%	Nik ModiRBC Capital 50%	164 164	Previous Sector Perform Current Sector Perform	Get Alert
Jan 23, 2025	PGProcter & Gamble	$150.79	9.42%	Mark AstrachanStifel 74%	161 165	Previous Hold Current Hold	Get Alert
Jan 23, 2025	PGProcter & Gamble	$150.79	19.37%	Chris CareyWells Fargo 62%	176 180	Previous Overweight Current Overweight	Get Alert
Jan 23, 2025	PGProcter & Gamble	$150.79	5.44%	Lauren LiebermanBarclays 64%	155 159	Previous Equal-Weight Current Equal-Weight	Get Alert
Jan 23, 2025	PGProcter & Gamble	$150.79	38.6%	Linda Bolton WeiserDA Davidson 54%	209 209	Previous Buy Current Buy	Get Alert
Jan 22, 2025	PGProcter & Gamble	$150.79	14.73%	Korinne WolfmeyerPiper Sandler 49%	173 174	Previous Neutral Current Neutral	Get Alert
Jan 17, 2025	PGProcter & Gamble	$150.79	2.79%	Lauren LiebermanBarclays 64%	155 163	Previous Equal-Weight Current Equal-Weight	Get Alert
Jan 17, 2025	PGProcter & Gamble	$150.79	6.77%	Mark AstrachanStifel 74%	161 167	Previous Hold Current Hold	Get Alert
Jan 16, 2025	PGProcter & Gamble	$150.79	25.34%	Peter GromUBS 62%	189 196	Previous Buy Current Buy	Get Alert
Jan 16, 2025	PGProcter & Gamble	$150.79	20.03%	Andrea TeixeiraJP Morgan 62%	181 186	Previous Overweight Current Overweight	Get Alert
Jan 7, 2025	PGProcter & Gamble	$150.79	16.72%	Chris CareyWells Fargo 62%	176 190	Previous Overweight Current Overweight	Get Alert
Dec 27, 2024	PGProcter & Gamble	$150.79	38.6%	Linda Bolton WeiserDA Davidson 54%	209 209	Previous Buy Current Buy	Get Alert
Nov 25, 2024	PGProcter & Gamble	$150.79	38.6%	Linda Bolton WeiserDA Davidson 54%	160 209	Previous Neutral Current Buy	Get Alert
Nov 22, 2024	PGProcter & Gamble	$150.79	26%	Chris CareyWells Fargo 62%	188 190	Previous Overweight Current Overweight	Get Alert
Nov 20, 2024	PGProcter & Gamble	$150.79	6.11%	Linda Bolton WeiserDA Davidson 54%	160 160	Previous Neutral Current Neutral	Get Alert
Oct 21, 2024	PGProcter & Gamble	$150.79	26.66%	Dara MohsenianMorgan Stanley 73%	174 191	Previous Overweight Current Overweight	Get Alert
Oct 21, 2024	PGProcter & Gamble	$150.79	21.36%	Robert OttensteinEvercore ISI Group 53%	180 183	Previous Outperform Current Outperform	Get Alert
Oct 21, 2024	PGProcter & Gamble	$150.79	8.76%	Nik ModiRBC Capital 50%	164 164	Previous Sector Perform Current Sector Perform	Get Alert
Oct 21, 2024	PGProcter & Gamble	$150.79	6.11%	Linda Bolton WeiserDA Davidson 54%	159 160	Previous Neutral Current Neutral	Get Alert
Oct 15, 2024	PGProcter & Gamble	$150.79	5.44%	Linda Bolton WeiserDA Davidson 54%	159 159	Previous Neutral Current Neutral	Get Alert
Oct 9, 2024	PGProcter & Gamble	$150.79	5.44%	Linda Bolton WeiserDA Davidson 54%	159	Previous Initiates Current Neutral	Get Alert
Sep 30, 2024	PGProcter & Gamble	$150.79	8.1%	Lauren LiebermanBarclays 64%	163 163	Previous Overweight Current Equal-Weight	Get Alert
Sep 24, 2024	PGProcter & Gamble	$150.79	15.39%	Korinne WolfmeyerPiper Sandler 49%	174	Previous Initiates Current Neutral	Get Alert
Sep 19, 2024	PGProcter & Gamble	$150.79	23.35%	Andrea TeixeiraJP Morgan 62%	179 186	Previous Overweight Current Overweight	Get Alert
Aug 29, 2024	PGProcter & Gamble	$150.79	26%	Michael PohnDZ Bank 9%	190	Previous Hold Current Buy	Get Alert
Aug 1, 2024	PGProcter & Gamble	$150.79	8.1%	Lauren LiebermanBarclays 64%	163 174	Previous Overweight Current Overweight	Get Alert
Jul 31, 2024	PGProcter & Gamble	$150.79	18.71%	Andrea TeixeiraJP Morgan 62%	179 181	Previous Overweight Current Overweight	Get Alert
Jul 31, 2024	PGProcter & Gamble	$150.79	8.76%	Nik ModiRBC Capital 50%	157 164	Previous Sector Perform Current Sector Perform	Get Alert
Jul 24, 2024	PGProcter & Gamble	$150.79	16.05%	Kaumil GajrawalaJefferies 52%	175 182	Previous Buy Current Hold	Get Alert
Jul 23, 2024	PGProcter & Gamble	$150.79	25.34%	Robert MoskowTD Cowen 65%	189	Previous Initiates Current Buy	Get Alert
Jul 22, 2024	PGProcter & Gamble	$150.79	20.03%	Andrea TeixeiraJP Morgan 62%	170 181	Previous Overweight Current Overweight	Get Alert
Jul 22, 2024	PGProcter & Gamble	$150.79	6.77%	Mark AstrachanStifel 74%	157 161	Previous Hold Current Hold	Get Alert
Jul 19, 2024	PGProcter & Gamble	$150.79	15.39%	Lauren LiebermanBarclays 64%	170 174	Previous Overweight Current Overweight	Get Alert
Jul 18, 2024	PGProcter & Gamble	$150.79	21.36%	Robert OttensteinEvercore ISI Group 53%	177 183	Previous Outperform Current Outperform	Get Alert
Jul 17, 2024	PGProcter & Gamble	$150.79	16.72%	Steve PowersDeutsche Bank 66%	171 176	Previous Buy Current Buy	Get Alert
Jul 10, 2024	PGProcter & Gamble	$150.79	26%	Filippo FalorniCitigroup 57%	177 190	Previous Buy Current Buy	Get Alert
Jun 24, 2024	PGProcter & Gamble	$150.79	24.01%	Kevin GrundyExane BNP Paribas 53%	187	Previous Initiates Current Outperform	Get Alert
Apr 25, 2024	PGProcter & Gamble	$150.79	22.68%	Chris GrajaArgus Research 65%	180 185	Previous Buy Current Buy	Get Alert
Apr 23, 2024	PGProcter & Gamble	$150.79	12.74%	Lauren LiebermanBarclays 64%	168 170	Previous Overweight Current Overweight	Get Alert
Apr 22, 2024	PGProcter & Gamble	$150.79	13.4%	Steve PowersDeutsche Bank 66%	171 172	Previous Buy Current Buy	Get Alert
Apr 22, 2024	PGProcter & Gamble	$150.79	20.7%	Kaumil GajrawalaJefferies 52%	175 182	Previous Buy Current Buy	Get Alert

Recent Analyst Stock Rating News

PRO

Keefe, Bruyette & Woods Maintains Outperform on American Integrity, Raises Price Target to $31

Keefe, Bruyette & Woods analyst Tommy McJoynt maintains American Integrity (NYSE:AII) with a Outperform and raises the price target from $29 to $31.

Why Is Shopify Stock Gaining Monday?

Shopify (SHOP) stock rises premarket as Cantor Fitzgerald bumps target to $158. Check analyst ratings, technicals & earnings forecast.

PRO

Keefe, Bruyette & Woods Maintains Outperform on American International Gr, Lowers Price Target to $90

Keefe, Bruyette & Woods analyst Meyer Shields maintains American International Gr (NYSE:AIG) with a Outperform and lowers the price target from $96 to $90.

PRO

Leerink Partners Assumes Equillium at Outperform, Announces Price Target of $6

Leerink Partners analyst Will Soghikian assumes Equillium (NASDAQ:EQ) with a Outperform rating and announces Price Target of $6.

PRO

Leerink Partners Assumes Connect Biopharma Hldgs at Outperform, Announces Price Target of $4

Leerink Partners analyst Will Soghikian assumes Connect Biopharma Hldgs (NASDAQ:CNTB) with a Outperform rating and announces Price Target of $4.

PRO

Keefe, Bruyette & Woods Maintains Market Perform on American Financial Group, Lowers Price Target to $147

Keefe, Bruyette & Woods analyst Meyer Shields maintains American Financial Group (NYSE:AFG) with a Market Perform and lowers the price target from $153 to $147.

PRO

Leerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40

Leerink Partners analyst Will Soghikian initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Outperform rating and announces Price Target of $40.

PRO

Keefe, Bruyette & Woods Maintains Market Perform on Arch Capital Group, Lowers Price Target to $95

Keefe, Bruyette & Woods analyst Meyer Shields maintains Arch Capital Group (NASDAQ:ACGL) with a Market Perform and lowers the price target from $99 to $95.

PRO

Leerink Partners Initiates Coverage On Vera Therapeutics with Market Perform Rating, Announces Price Target of $34

Leerink Partners analyst Will Soghikian initiates coverage on Vera Therapeutics (NASDAQ:VERA) with a Market Perform rating and announces Price Target of $34.

PRO

Leerink Partners Initiates Coverage On Nektar Therapeutics with Outperform Rating, Announces Price Target of $130

Leerink Partners analyst Will Soghikian initiates coverage on Nektar Therapeutics (NASDAQ:NKTR) with a Outperform rating and announces Price Target of $130.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

What Are Analyst Stock Ratings?

Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders.

Analysts arrive at stock ratings after they research companies’ public financial statements, communicate with executives and customers and interact with companies in other ways.

Most analysts issue ratings 4 times a year, usually at 3-month intervals.

How to Use Analyst Ratings

As an investor or trader, you want to be able to use analyst ratings effectively. Here are steps you can take to understand how to synthesize all the information analysts report about a particular company and how to apply it to your own trades.

Step 1: Check Ratings History

In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the previous rating and whether a price target gets announced or changed.

Sometimes the rating stays the same and only the price target changes, which could cause the stock to move in either direction, depending on the significance of the change between the 2 price targets.

Step 2: Check for Other News

In the short term, check to see how the stock reacts to positive or negative news. This will be an indication of the company’s outlook because analyst ratings usually come out after the company announces news (it’ll typically be earnings news).

Step 3: Look at the Sector for News

Check to see if other stocks in the sector also received similar ratings. This could indicate micro news, which refers to when the whole sector or specific company trades in a specific way due to news outside of one company.

Step 4: Look at the Note

If available, look over the analyst note itself. The beginning of the note has the main information of the rating and price target. Investors should also take a look at the summary of the note, which you can find in the first couple pages and give you a concrete overview of the company. This can help you get an understanding of how analysts arrived at their thesis on the stock.

An example of an analyst note. Source: Needham

Step 5: Make a Decision

After reviewing the analyst ratings (and whether the analyst proposes a change or initiation) and find the reason for that note. Make a decision based on the analyst thesis on the company. This should give you guidance on how to make your thesis. Analyst ratings are a good indication of what professionals believe the company or sector will do, helping you get a better understanding of the companies you’re interested in.

Analyst Rating Accuracy

Analyst ratings are not set in stone and nobody knows indefinitely what a stock will do. Therefore, analyst ratings should be taken as an educated guess made by professionals who carefully study the specific company and sector in question. It's not a surprise that the accuracy of each rating can vary by each individual analyst and specific ratings on companies.

In other words, there’s no hard number or percentage on how accurate analyst ratings are because they are like educated guesses on what they think the stock will do based on their research, within that particular sector. In addition, each firm has so many analysts and so many different companies to review that you can compare ratings to glean what you believe is the truth.

Where Analyst Ratings Come From

Analyst ratings come from stock analysts. Analysts “go deep” on companies within a particular industry or sector. Some analysts employ a top-down approach (they start with an industry or sector and look for excellent companies within that industry or sector) and other stock analysts choose a bottom-up approach, which means they start with the company first and connect the dots within that company’s sector or industry. Analysts evaluate:

Financial statements
Economic fundamentals
Suppliers, customers and competitors
Management quality
Business model
Revenue
Expenses
Assets
Liabilities

While these evaluations are done using facts and figures that any investor can access, they come down to a conclusion the analyst must draw. While this isn’t an unqualified opinion, analysts will disagree because their interpretations of the data could vary.

Types of Stock Ratings

Stock ratings can range from simple “buy” and “sell” ratings to “equal weight” and “outperform” ratings. Here’s a quick overview of how analysts rate stocks.

Buy Rating

A “buy” rating indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and recommends that traders purchase the stock. An analyst may even go so far as to indicate that a stock is a “strong buy.” At the same time, you may choose to swing trade the asset for a profit and come back later to start the process all over again.

Sell Rating

A “sell” rating means that an analyst believes the stock will trend downward in a particular time frame. Analysts might even refer to a security as a “strong sell.” Remember, though, you may want to swing trade and come back to this asset in the future even though you just chose to sell, just as you would under a “buy” rating.

Hold

A “hold” rating suggests that investors should not buy more of or sell the specified stock because they believe the stock should perform in a way that’s consistent with the market or will perform similarly to comparable companies within that particular sector. This is akin to the value investing approach that Warren Buffett uses, looking to gain long-term value from a single stock rather than flipping it because of a bad week. As many have said, it’s not a loss until you sell.

Underperform

An “underperform” rating means an analyst indicates that a stock is expected to perform below the market or sector average. And yes, while the underperform rating may not bode well for an asset in the next few weeks, it may not stay that way. Continue to carefully monitor your portfolio to ensure that an underperforming asset hasn’t turned itself around. As companies are faced with the Herculean task of pleasing shareholders, they will push to fix their underperforming stocks, meaning that a stock you wrote off could rise again.

Outperform

An “outperform” rating means that an analyst expects a stock to outperform the market or sector average. While the stock may look to outperform the market or a sector’s average, that doesn’t mean it will continue to soar forever. You must look at an outperform rating as what that asset will do in recent times, but it may not maintain that trajectory.

Equal-Weight

An equal weight rating means that an analyst believes that an individual stock's performance will tie to the average of all the stocks that an analyst covers in that particular sector. This type of rating helps investors get a true comparison of stocks to each other within a particular sector or industry. At the same time, equal-weight ratings could change at any time.

Price Target

A price target is an analyst’s projection of a stock’s future price. A price target is generally set up in a general trade or area where the asset might land. This means that the analyst could get close without hitting the figure on the head. Even so, the analyst wants to get close and better predict the movement of the marketplace and the asset.

Understanding Stock Ratings

Stock ratings are assessments of the investment potential of a particular stock. They are typically created by financial analysts who evaluate a company's financial performance, competitive positioning, and market outlook to provide guidance on the stock's expected future performance.

Ratings typically range from "buy" to "sell," with variations in between, such as "hold," "accumulate," or "neutral." A "buy" rating suggests that the stock is likely to perform well in the future, and investors should consider purchasing it. Conversely, a "sell" rating indicates that the stock is expected to underperform, and investors should consider selling it.

It's important to note that ratings are not guarantees of performance and should not be relied upon solely when making investment decisions. Ratings are just one factor to consider when evaluating a stock's potential, and investors should also conduct their own research and analysis to make informed decisions.

Another thing to keep in mind is that different analysts may have different opinions on a stock, so it's a good idea to consider multiple ratings before making an investment decision.

In addition to analyst ratings, investors can also consider other factors when evaluating a stock, such as its financial statements, management team, industry trends, and overall market conditions. By combining all of these factors, investors can make informed decisions about which stocks to buy or sell.

In summary, stock ratings are an important tool for investors to consider when evaluating a stock's potential, but they should not be the only factor used in investment decision-making. It's important to conduct your own research, consider multiple ratings, and take into account other factors before making an investment decision.

Should You Use Analyst Ratings to Inform Your Own Trades?

You can definitely use analyst ratings to inform your own trades and inform your own thesis but it’s a good idea to do your own research. However, analyst ratings are just one step in what should be a much larger investment strategy. Don’t fall in love with just one analyst. Compare notes. Look into how these ratings match with activity on the market and current events. Plus, remember that an analyst rating could easily be incorrect. No one is perfect, but these ratings are a good place to start.

Visit Benzinga News for more guidance on how to research companies and make decisions about research, trading and investing.

Compare Online Stock Brokers

Claim Exclusive Offers

Interactive Brokers Review
Good Fit For:
Active and Global Traders
VIEW PROS & CONS:
Securely through Interactive Brokers’ website
Plus500 Review
Good Fit For:
Leveraged Trading
VIEW PROS & CONS:
securely through Plus500 Yield's website
public.com Review
Good Fit For:
Trading Ideas
VIEW PROS & CONS:
securely through public.com's website
Robinhood Review
Good Fit For:
Commission-Free Mobile Trading
VIEW PROS & CONS:
securely through Robinhood's website
TradeZero Review
Good Fit For:
Active Short Sellers
VIEW PROS & CONS:
securely through TradeZero [SPONSORED]'s website